Tenaya Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$50M
Industry:Biotech
Founded:2016
Lead Investor(s):N/A

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Tenaya Therapeutics's estimated annual revenue is currently $10.4M per year.
  • Tenaya Therapeutics's estimated revenue per employee is $155,000
  • Tenaya Therapeutics's total funding is $50M.

Employee Data

  • Tenaya Therapeutics has 67 Employees.
  • Tenaya Therapeutics grew their employee count by 31% last year.
  • Tenaya Therapeutics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$7M4510%N/A-N/A
#2
N/A205N/AN/A-N/A
#3
$46.8M3024%N/A-N/A
#4
$22.3M144N/AN/A-N/A
#5
$44.3M286N/AN/A-N/A
#6
$101.2M65346%N/A-N/A
#7
$33.3M2153%N/A-N/A
#8
$28.7M1858%N/A-N/A
#9
$39.4M254N/AN/A-N/A
#10
$6.5M4214%N/A-N/A
Missing a competitor? Contribute!?
Submit

Tenaya Therapeutics is a privately-held biopharmaceutical company backed by The Column Group. The Company was founded in 2016 by world-leading scientists from the Gladstone Institute's Cardiovascular Division and the University of Texas Southwestern Medical Center. Tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration. Tenaya has a lead gene therapy program focused on in vivo reprogramming of cardiac fibroblasts to cardiomyocytes to regenerate heart tissue, and additional programs focused on cardiomyopathies.

keywords:N/A

67

Number of Employees

$10.4M

Revenue (est)

1

Current Jobs

31%

Employee Growth %

$50M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Tenaya Therapeutics News

03/13/2019 - Tenaya Therapeutics Strengthens Leadership Team with ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tenaya Therapeutics a biopharmaceutical company focused on developing potentially ...

03/14/2019 - Tenaya Therapeutics adds two pharma veterans to leadership ...

California, USA-based biopharma company Tenaya Therapeutics, which is focused on developing potentially curative treatments for heart ...

30 lip 2018 - Tenaya Therapeutics Appoints Faraz Ali as Chief Executive ...

SOUTH SAN FRANCISCO, Calif., July 30, 2018 /PRNewswire/ -- Tenaya Therapeutics, a preclinical-stage biotechnology company focused on ...

Tenaya Therapeutics Executive Hires

DateNameTitleReference
2017-11-02Tim HoeyChief Scientific OfficerArticle
2018-07-31Faraz AliChief Executive OfficerArticle
2019-03-14Whittemore TingleyChief Medical OfficerArticle